Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling

Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas

Ciceroni, C
Bonelli, M
Mastrantoni, E
Niccolini, C
Laurenza, M
Larocca, Lm (ORCID:0000-0003-1739-4758)
Pallini, R (ORCID:0000-0002-4611-8827)
Traficante, A
Spinsanti, P
Ricci-Vitiani, L
Arcella, A
De Maria Marchiano, Ruggero (ORCID:0000-0003-2255-0583)
Nicoletti, F
Battaglia, G
Melchiorri, D.

January 2013

Drug treatment of malignant gliomas is limited by the intrinsic resistance of glioma stem cells (GSC...

Transcriptional control of O -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma

Happold, Caroline
Stojcheva, Nina
Silginer, Manuela
Weiss, Tobias
Roth, Patrick
Reifenberger, Guido
Weller, Michael

March 2018

O -methylguanine DNA methyltransferase (MGMT) promoter methylation is a predictive biomarker for ben...

Transcriptional control of O -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma

Happold, Caroline
Stojcheva, Nina
Silginer, Manuela
Weiss, Tobias
Roth, Patrick
Reifenberger, Guido
Weller, Michael

March 2018

O -methylguanine DNA methyltransferase (MGMT) promoter methylation is a predictive biomarker for ben...

and Clinical Oncology

Nakada Mitsutoshi
Sabit Hemragul
Lei Teng
Furuyama Natsuki
Hayashi Yutaka
Ilya V. Pyko

January 2013

Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affect...

Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling

ピコイリア
Pyko Ilya Vassilyevich

September 2013

13301甲第3924号博士（医学）金沢大学博士論文本文Full 以下に掲載：Carcinogenesis 34(10) pp.2206-2217 2013. Oxford University Pr...

Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions.

Agnieszka Belter
Jakub Barciszewski
Anna-Maria Barciszewska

January 2020

Temozolomide (TMZ) is a drug of choice in glioblastoma treatment. Its therapeutic applications expan...

Analyzes of the effects of O6-methylguanine DNA methyltransferase (MGMT) on the reactivity of glioblastoma multiforme cells to temozolomide

Kochanowski, Paweł

Glejak wielopostaciowy to największy problem współczesnej neuroonkologii. Podstawą terapii tego wyso...

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression

Gloria Perazzoli (811155)
Jose Prados (778445)
Raul Ortiz (778443)
Octavio Caba (811156)
Laura Cabeza (811157)
Maria Berdasco (5665351)
Beatriz Gónzalez (5665354)
Consolación Melguizo (5665357)

October 2015

<div>BackgroundThe use of temozolomide (TMZ) has improved the prognosis for glioblastoma m...

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression

Perazzoli, Gloria
Prados, Jose
Ortiz, Raul
Caba, Octavio
Cabeza, Laura
Berdasco, María
González Navarro, Beatriz
Melguizo, Consolación

Background: The use of temozolomide (TMZ) has improved the prognosis for glioblastoma multiforme pat...

A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells.

Anna-Maria Barciszewska
Dorota Gurda
Paweł Głodowicz
Stanisław Nowak
Mirosława Z Naskręt-Barciszewska

Temozolomide (TMZ) is an oral alkylating chemotherapeutic agent that prolongs the survival of patien...

Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas

Ciceroni, C.
Bonelli, M.
Mastrantoni, E.
Niccolini, C.
Laurenza, M.
Larocca, L. M. (ORCID:0000-0003-1739-4758)
Pallini, R. (ORCID:0000-0002-4611-8827)
Traficante, A.
Spinsanti, P.
Ricci-Vitiani, L.
Arcella, A.
De Maria Marchiano, R. (ORCID:0000-0003-2255-0583)
Nicoletti, F.
Battaglia, G.
Melchiorri, D.

January 2013

Drug treatment of malignant gliomas is limited by the intrinsic resistance of glioma stem cells (GSC...

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.

Gloria Perazzoli
Jose Prados
Raul Ortiz
Octavio Caba
Laura Cabeza
Maria Berdasco
Beatriz Gónzalez
Consolación Melguizo

The use of temozolomide (TMZ) has improved the prognosis for glioblastoma multiforme patients. Howev...

<it>O</it><it>6</it>-<it>methylguanine-DNA methyltransferase </it>is downregulated in transformed astrocyte cells: implications for anti-glioma therapies

Kaneko Sadao
Tabu Kouichi
Aoyanagi Eiko
Akagi Tsuyoshi
Sasai Ken
Tanaka Shinya

June 2007

Abstract Background A novel alkylating agent, temozolomide, has proven efficacious in the treatment ...

Effects of Glycogen Synthase Kinase-3β (GSK3β) Inhibition in Glioblastoma Using Novel Compounds

Rzepecka, Klaudia
Lawrence, Clare Louise
Moualla, Dima
Hayes, Joseph
Alder, Jane Elizabeth

October 2022

Abstract AIMS GSK3β is a constitutively conserved serine/threonine kinase involved in a number of bi...

Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas

CICERONI, CINZIA
BONELLI, MILTON
NICCOLINI, CRISTIANO
LAURENZA, MARTA
SPINSANTI, Paola
NICOLETTI, Ferdinando
BATTAGLIA, Giuseppe
MELCHIORRI, Daniela
E. Mastrantoni
L. M. Larocca
R. Pallini
A. Traficante
L. Ricci Vitiani
A. Arcella
R. De Maria

January 2013

Drug treatment of malignant gliomas is limited by the intrinsic resistance of glioma stem cells (GSC...

Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas

Ciceroni, C
Bonelli, M
Mastrantoni, E
Niccolini, C
Laurenza, M
Larocca, Lm (ORCID:0000-0003-1739-4758)
Pallini, R (ORCID:0000-0002-4611-8827)
Traficante, A
Spinsanti, P
Ricci-Vitiani, L
Arcella, A
De Maria Marchiano, Ruggero (ORCID:0000-0003-2255-0583)
Nicoletti, F
Battaglia, G
Melchiorri, D.

January 2013

Drug treatment of malignant gliomas is limited by the intrinsic resistance of glioma stem cells (GSC...

Transcriptional control of O -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma

Happold, Caroline
Stojcheva, Nina
Silginer, Manuela
Weiss, Tobias
Roth, Patrick
Reifenberger, Guido
Weller, Michael

March 2018

O -methylguanine DNA methyltransferase (MGMT) promoter methylation is a predictive biomarker for ben...

Transcriptional control of O -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma

Happold, Caroline
Stojcheva, Nina
Silginer, Manuela
Weiss, Tobias
Roth, Patrick
Reifenberger, Guido
Weller, Michael

March 2018

O -methylguanine DNA methyltransferase (MGMT) promoter methylation is a predictive biomarker for ben...

and Clinical Oncology

Nakada Mitsutoshi
Sabit Hemragul
Lei Teng
Furuyama Natsuki
Hayashi Yutaka
Ilya V. Pyko

January 2013

Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affect...

Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling

ピコイリア
Pyko Ilya Vassilyevich

September 2013

13301甲第3924号博士（医学）金沢大学博士論文本文Full 以下に掲載：Carcinogenesis 34(10) pp.2206-2217 2013. Oxford University Pr...

Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions.

Agnieszka Belter
Jakub Barciszewski
Anna-Maria Barciszewska

January 2020

Temozolomide (TMZ) is a drug of choice in glioblastoma treatment. Its therapeutic applications expan...

Analyzes of the effects of O6-methylguanine DNA methyltransferase (MGMT) on the reactivity of glioblastoma multiforme cells to temozolomide

Kochanowski, Paweł

Glejak wielopostaciowy to największy problem współczesnej neuroonkologii. Podstawą terapii tego wyso...

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression

Gloria Perazzoli (811155)
Jose Prados (778445)
Raul Ortiz (778443)
Octavio Caba (811156)
Laura Cabeza (811157)
Maria Berdasco (5665351)
Beatriz Gónzalez (5665354)
Consolación Melguizo (5665357)

October 2015

<div>BackgroundThe use of temozolomide (TMZ) has improved the prognosis for glioblastoma m...

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression

Perazzoli, Gloria
Prados, Jose
Ortiz, Raul
Caba, Octavio
Cabeza, Laura
Berdasco, María
González Navarro, Beatriz
Melguizo, Consolación

Background: The use of temozolomide (TMZ) has improved the prognosis for glioblastoma multiforme pat...

A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells.

Anna-Maria Barciszewska
Dorota Gurda
Paweł Głodowicz
Stanisław Nowak
Mirosława Z Naskręt-Barciszewska

Temozolomide (TMZ) is an oral alkylating chemotherapeutic agent that prolongs the survival of patien...

Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas

Ciceroni, C.
Bonelli, M.
Mastrantoni, E.
Niccolini, C.
Laurenza, M.
Larocca, L. M. (ORCID:0000-0003-1739-4758)
Pallini, R. (ORCID:0000-0002-4611-8827)
Traficante, A.
Spinsanti, P.
Ricci-Vitiani, L.
Arcella, A.
De Maria Marchiano, R. (ORCID:0000-0003-2255-0583)
Nicoletti, F.
Battaglia, G.
Melchiorri, D.

January 2013

Drug treatment of malignant gliomas is limited by the intrinsic resistance of glioma stem cells (GSC...

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.

Gloria Perazzoli
Jose Prados
Raul Ortiz
Octavio Caba
Laura Cabeza
Maria Berdasco
Beatriz Gónzalez
Consolación Melguizo

The use of temozolomide (TMZ) has improved the prognosis for glioblastoma multiforme patients. Howev...

<it>O</it><it>6</it>-<it>methylguanine-DNA methyltransferase </it>is downregulated in transformed astrocyte cells: implications for anti-glioma therapies

Kaneko Sadao
Tabu Kouichi
Aoyanagi Eiko
Akagi Tsuyoshi
Sasai Ken
Tanaka Shinya

June 2007

Abstract Background A novel alkylating agent, temozolomide, has proven efficacious in the treatment ...

Effects of Glycogen Synthase Kinase-3β (GSK3β) Inhibition in Glioblastoma Using Novel Compounds

Rzepecka, Klaudia
Lawrence, Clare Louise
Moualla, Dima
Hayes, Joseph
Alder, Jane Elizabeth

October 2022

Abstract AIMS GSK3β is a constitutively conserved serine/threonine kinase involved in a number of bi...

Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas

CICERONI, CINZIA
BONELLI, MILTON
NICCOLINI, CRISTIANO
LAURENZA, MARTA
SPINSANTI, Paola
NICOLETTI, Ferdinando
BATTAGLIA, Giuseppe
MELCHIORRI, Daniela
E. Mastrantoni
L. M. Larocca
R. Pallini
A. Traficante
L. Ricci Vitiani
A. Arcella
R. De Maria

January 2013

Drug treatment of malignant gliomas is limited by the intrinsic resistance of glioma stem cells (GSC...

Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas

Ciceroni, C
Bonelli, M
Mastrantoni, E
Niccolini, C
Laurenza, M
Larocca, Lm (ORCID:0000-0003-1739-4758)
Pallini, R (ORCID:0000-0002-4611-8827)
Traficante, A
Spinsanti, P
Ricci-Vitiani, L
Arcella, A
De Maria Marchiano, Ruggero (ORCID:0000-0003-2255-0583)
Nicoletti, F
Battaglia, G
Melchiorri, D.

January 2013

Drug treatment of malignant gliomas is limited by the intrinsic resistance of glioma stem cells (GSC...

Transcriptional control of O -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma

Happold, Caroline
Stojcheva, Nina
Silginer, Manuela
Weiss, Tobias
Roth, Patrick
Reifenberger, Guido
Weller, Michael

March 2018

O -methylguanine DNA methyltransferase (MGMT) promoter methylation is a predictive biomarker for ben...

Transcriptional control of O -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma

Happold, Caroline
Stojcheva, Nina
Silginer, Manuela
Weiss, Tobias
Roth, Patrick
Reifenberger, Guido
Weller, Michael

March 2018

O -methylguanine DNA methyltransferase (MGMT) promoter methylation is a predictive biomarker for ben...

Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling

Abstract

Extracted data

Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling

Abstract

Extracted data

Related items

Related items